SXTP
60 Degrees Pharmaceuticals, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.94M
P/E Ratio
—
EPS
$-6.76
Beta
2.70
52W High
$14.68
52W Low
$1.29
50-Day MA
$1.71
200-Day MA
$3.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About 60 Degrees Pharmaceuticals, Inc. Common Stock
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company is headquartered in Washington, District of Columbia.
Fundamentals
| Revenue (TTM) | $1.31M |
| Gross Profit (TTM) | $-1.50M |
| EBITDA | $-7.85M |
| Operating Margin | -1292.00% |
| Return on Equity | -172.80% |
| Return on Assets | -77.90% |
| Revenue/Share (TTM) | $1.29 |
| Book Value | $-1.80 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 2.99 |
| EV/Revenue | 10.33 |
| EV/EBITDA | 22.23 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -36.80% |
| Shares Outstanding | $2.66M |
| Float | $2.44M |
| % Insiders | 1.20% |
| % Institutions | 9.60% |
Analyst Ratings
Consensus ($3.70 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026